Acute Myeloblastic Leukemia research hub

Single-centre Phase I/II study with dose escalation of tocilizumab in combination with venetoclax and azacitidine chemotherapy in patients with Acute Myeloid Leukaemia (AML): TOCIVENA

This study is looking at a new way to treat Acute Myeloid Leukaemia (AML), a type of blood cancer. Researchers are testing a combination of three medicines, including one that helps calm the immune system, to see if they work better together for adults with AML.